Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

50.24 +0.57 (+1.15%)

Streaming Delayed Price Updated: 3:05 PM EDT, May 18, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	2,108,574
Open	49.79
Bid (Size)	50.25 (100)
Ask (Size)	50.26 (300)
Prev. Close	49.67
Today's Range	49.79 - 50.53
52wk Range	35.45 - 61.70
Shares Outstanding	5,385,189,617
Dividend Yield	3.87%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Julie Bowen and Ty Burrell team up with GSK to raise awareness about meningitis risks for teens and young adults

May 07, 2026

From GSK plc

Via Business Wire

The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat ↗

May 02, 2026

Via MarketBeat

Performance

YTD	+1.2%	+1.2%
1 Month	-13.9%	-13.9%
3 Month	-17.5%	-17.5%
6 Month	+5.7%	+5.7%
1 Year	+32.3%	+32.3%

More News

Mondrian Dumps 5.5 Million Yum China Shares Worth $284.6 Million ↗

April 29, 2026

Via The Motley Fool

Nvidia Rival Cerebras Files for an IPO: What Investors Should Know ↗

April 20, 2026

Via The Motley Fool

3 Bargain-Cheap Small Caps Worth a Second Look ↗

April 09, 2026

Via MarketBeat

The "Liberation Day" Shockwave: US Finalizes 100% Tariffs on Branded Pharmaceutical Imports

April 06, 2026

Via MarketMinute

Merck’s Oncology Empire Expands: Keytruda Secures Pivotal European Commission Approval for Recurrent Ovarian Cancer

April 02, 2026

Via MarketMinute

Moderna 2.0: The mRNA Pioneer’s Pivot to Oncology and the Path to 2028 Profitability

March 31, 2026

Via Finterra

AstraZeneca (AZN) Shares Rally After Breakthrough Chronic Lung Disease Trial Results

March 27, 2026

Via MarketMinute

The mRNA Renaissance: Moderna’s 83% Surge Leads the 2026 Healthcare Recovery

March 16, 2026

Via MarketMinute

This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment ↗

March 16, 2026

Via The Motley Fool

The $40 Billion Pivot: Kimberly-Clark and Kenvue Merger Redefines the Consumer Staples Landscape

March 16, 2026

Via MarketMinute

This Life Sciences Supplier Has Plunged 50% in a Year, but One Fund Bought Up $28 Million More in Stock ↗

March 16, 2026

Via The Motley Fool

Amgen, GSK Set To Join TrumpRx Offering Deep Prescription Drug Discounts: Report ↗

March 16, 2026

Via Benzinga

GSK’s RSV Vaccine, AREXVY, Approved in US for Expanded Age Indication in Adults Aged 18–49 Years at Increased Risk

March 13, 2026

From GSK plc

Via Business Wire

The Moderna Pivot: Analyzing the 14% Surge and the Future of mRNA Oncology

March 06, 2026

Via Finterra

Moderna’s Renaissance: Why MRNA Surged 16% as the mRNA Platform Enters the Oncology Era

March 05, 2026

Via Finterra

Merck's Two-Drug HIV Regimen Challenges Industry Standards Following Positive Phase 3 Results

February 26, 2026

Via MarketMinute

AstraZeneca’s Strategic Leap: Pharmaceutical Giant Completes Historic Move to the New York Stock Exchange

February 26, 2026

Via MarketMinute

United Therapeutics (UTHR) Deep Dive: Strong Q4 and the ‘Inhalation Evolution’

February 26, 2026

Via Finterra

Gilead’s Twice-Yearly HIV Breakthrough: A Paradigm Shift in Global Prevention and Market Dominance

February 25, 2026

Via MarketMinute

Bora Pharmaceuticals and GSK Sign $250M Five Year Global Manufacturing Contract

February 23, 2026

From Bora Pharmaceuticals Co., Ltd.

Via Business Wire

GSK’s AREXVY Associated With Reductions in Certain RSV-Related Risks Including Heart Attack, Stroke and Severe Flare-Ups of COPD and Asthma, Real World Study Shows

February 18, 2026

From GSK plc

Via Business Wire

Moderna’s mRNA Renaissance: Navigating Volatility and the Post-Pandemic Pipeline

February 17, 2026

Via Finterra

Moderna Shares Surge as Aggressive Cost-Cutting and Post-Pandemic Pivot Take Hold in Q4 Results

February 13, 2026

Via MarketMinute

Frequently Asked Questions

Is GSK plc American Depositary Shares (Each representing two Ordinary Shares) publicly traded?

Yes, GSK plc American Depositary Shares (Each representing two Ordinary Shares) is publicly traded.

What exchange does GSK plc American Depositary Shares (Each representing two Ordinary Shares) trade on?

GSK plc American Depositary Shares (Each representing two Ordinary Shares) trades on the New York Stock Exchange

What is the ticker symbol for GSK plc American Depositary Shares (Each representing two Ordinary Shares)?

The ticker symbol for GSK plc American Depositary Shares (Each representing two Ordinary Shares) is GSK on the New York Stock Exchange

What is the current price of GSK plc American Depositary Shares (Each representing two Ordinary Shares)?

The current price of GSK plc American Depositary Shares (Each representing two Ordinary Shares) is 50.24

When was GSK plc American Depositary Shares (Each representing two Ordinary Shares) last traded?

The last trade of GSK plc American Depositary Shares (Each representing two Ordinary Shares) was at 05/18/26 03:05 PM ET

What is the market capitalization of GSK plc American Depositary Shares (Each representing two Ordinary Shares)?

The market capitalization of GSK plc American Depositary Shares (Each representing two Ordinary Shares) is 270.55B

How many shares of GSK plc American Depositary Shares (Each representing two Ordinary Shares) are outstanding?

GSK plc American Depositary Shares (Each representing two Ordinary Shares) has 271B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.